Concurrent Investment Advisors’s AngioDynamics ANGO Stock Holding History

Concurrent Investment Advisors’s Portfolio ANGO Stock Details ANGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$246K	Buy	21,677 +15	+0.1%	+$163	﹤0.01%	1617
2025 Q4	$278K	Sell	21,662 -7,841	-27%	-$96.8K	﹤0.01%	1448
2025 Q3	$330K	Hold	29,503	–	–	0.01%	1112
2025 Q2	$293K	Hold	29,503	–	–	0.01%	1073
2025 Q1	$277K	Hold	29,503	–	–	0.01%	969
2024 Q4	$270K	Hold	29,503	–	–	0.01%	871
2024 Q3	$230K	Hold	29,503	–	–	0.01%	885
2024 Q2	$178K	Buy	29,503 +17,803	+152%	+$110K	0.01%	889
2024 Q1	$68.7K	Hold	11,700	–	–	﹤0.01%	869
2023 Q4	$91.7K	Buy	+11,700	New	+$81.2K	﹤0.01%	819

Other funds holding ANGO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

Broadfin Holdings Melville, New York $23.5M AUM

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

WCM

Weber Capital Management San Francisco, California $100M AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BAM

Bastion Asset Management Montreal, Canada $328M AUM 13.57% 1-Year Est. Return

Concurrent Investment Advisors's ANGO Position: Q1 2026 in Review

Concurrent Investment Advisors increased its AngioDynamics (ANGO) stake by 0.07% in Q1 2026, buying an estimated $163 and bringing the position to 21,677 shares worth $246K. The position accounts for ﹤0.01% of the portfolio, ranked #1617.

Concurrent Investment Advisors first reported a position in ANGO in Q4 2023 and has held it in 10 quarters since. The position peaked at $330K in Q3 2025. 147 funds tracked by Wall St. Rank hold ANGO as of Q1 2026.

Concurrent Investment Advisors held 21,677 shares of AngioDynamics worth $246K as of Q1 2026.
Concurrent Investment Advisors bought 15 AngioDynamics shares in Q1 2026, an estimated $163.
AngioDynamics made up ﹤0.01% of Concurrent Investment Advisors's portfolio in Q1 2026, its #1617 holding.
Concurrent Investment Advisors first reported a position in AngioDynamics in Q4 2023 and has held it in 10 quarters since.
Concurrent Investment Advisors's AngioDynamics position peaked at $330K in Q3 2025.
147 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2026.

Based on Concurrent Investment Advisors's 13F filing for Q1 2026, filed 21 Apr 2026.